Pharvaris Bv Stock Performance

PHVS Stock  USD 15.44  0.12  0.77%   
The company holds a Beta of 0.71, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Pharvaris' returns are expected to increase less than the market. However, during the bear market, the loss of holding Pharvaris is expected to be smaller as well. At this point, Pharvaris BV has a negative expected return of -0.31%. Please make sure to check Pharvaris' total risk alpha, as well as the relationship between the daily balance of power and relative strength index , to decide if Pharvaris BV performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Pharvaris BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more

Actual Historical Performance (%)

One Day Return
0.65
Five Day Return
(5.81)
Year To Date Return
(16.07)
Ten Year Return
(46.34)
All Time Return
(46.34)
JavaScript chart by amCharts 3.21.151234567Dec2025Feb -20-10010
JavaScript chart by amCharts 3.21.15Pharvaris BV Pharvaris BV Dividend Benchmark Dow Jones Industrial
1
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Invests 906,000 in Pharvaris - MarketBeat
12/20/2024
2
Pharvaris Sees Unusually-High Trading Volume - Heres Why - MarketBeat
01/03/2025
3
Pharvaris Outlines 2025 Strategic Priorities
01/13/2025
4
FY2026 EPS Estimates for Pharvaris Decreased by Analyst - Defense World
01/22/2025
5
JMP Securities Boosts Pharvaris Price Target to 55.00 - MarketBeat
02/03/2025
6
Pharvaris Sees Strong Trading Volume Whats Next
02/12/2025
7
We Think Pharvaris Can Afford To Drive Business Growth
02/26/2025
Begin Period Cash Flow161.8 M
  

Pharvaris Relative Risk vs. Return Landscape

If you would invest  1,915  in Pharvaris BV on November 30, 2024 and sell it today you would lose (359.00) from holding Pharvaris BV or give up 18.75% of portfolio value over 90 days. Pharvaris BV is currently does not generate positive expected returns and assumes 2.8419% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than Pharvaris, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
JavaScript chart by amCharts 3.21.15CashMarketPHVS 0.00.51.01.52.02.53.0 -0.35-0.30-0.25-0.20-0.15-0.10-0.050.00
       Risk  
Given the investment horizon of 90 days Pharvaris is expected to under-perform the market. In addition to that, the company is 3.88 times more volatile than its market benchmark. It trades about -0.11 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.08 per unit of volatility.

Pharvaris Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharvaris' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Pharvaris BV, and traders can use it to determine the average amount a Pharvaris' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.1097

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsPHVS

Estimated Market Risk

 2.84
  actual daily
25
75% of assets are more volatile

Expected Return

 -0.31
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.11
  actual daily
0
Most of other assets perform better
Based on monthly moving average Pharvaris is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pharvaris by adding Pharvaris to a well-diversified portfolio.

Pharvaris Fundamentals Growth

Pharvaris Stock prices reflect investors' perceptions of the future prospects and financial health of Pharvaris, and Pharvaris fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pharvaris Stock performance.
Return On Equity-0.59
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-70%-60%-50%-40%-30%-20%-10%
Return On Asset-0.33
Current Valuation517.5 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-70%-60%-50%-40%-30%-20%-10%
Shares Outstanding54.23 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%0%20%40%
Price To Book2.70 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%
EBITDA(96.85 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%
Net Income(99.83 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%
Cash And Equivalents201.38 M
Cash Per Share5.96 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%5,000%6,000%
Total Debt238.91 K
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%20%40%60%
Debt To Equity0 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-50%0%50%100%150%
Current Ratio12.85 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-70%-60%-50%-40%-30%-20%-10%
Book Value Per Share5.47 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%5,000%6,000%
Cash Flow From Operations(93.05 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%
Earnings Per Share(2.74) X
Market Capitalization843.87 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-40%-20%0%20%40%
Total Asset398.69 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312,000%4,000%6,000%8,000%10,000%
Retained Earnings(265.92 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%
Working Capital383.25 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31

About Pharvaris Performance

Assessing Pharvaris' fundamental ratios provides investors with valuable insights into Pharvaris' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Pharvaris is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand8.8 K6.7 K
Return On Tangible Assets(0.23)(0.24)
Return On Capital Employed(0.23)(0.24)
Return On Assets(0.23)(0.24)
Return On Equity(0.24)(0.25)

Things to note about Pharvaris BV performance evaluation

Checking the ongoing alerts about Pharvaris for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pharvaris BV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Pharvaris BV generated a negative expected return over the last 90 days
Pharvaris BV has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (99.83 M) with profit before overhead, payroll, taxes, and interest of 0.
Pharvaris BV currently holds about 201.38 M in cash with (93.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.96.
Pharvaris BV has a frail financial position based on the latest SEC disclosures
Over 89.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: We Think Pharvaris Can Afford To Drive Business Growth
Evaluating Pharvaris' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Pharvaris' stock performance include:
  • Analyzing Pharvaris' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pharvaris' stock is overvalued or undervalued compared to its peers.
  • Examining Pharvaris' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Pharvaris' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pharvaris' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Pharvaris' stock. These opinions can provide insight into Pharvaris' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Pharvaris' stock performance is not an exact science, and many factors can impact Pharvaris' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Pharvaris Stock Analysis

When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.